**Specifications Table**TableSubject area*Biology*More specific subject area*Radioprotective effect;Pharmacology*Type of data*Figure, pathology image, dot graph, band graph*How data was required*Flow cytometry, Microplate Reader, fluorescence staining*Data format*Analyzed*Experimental factors*Pretreatment with 15,30,60 mg/kg/day emodin for 7 days to mice before exposing to radiation*Experiment features*Analysis with tissue staining,Hoechst staining and Western blot in vivo*Data source lacation*Shanghai, China*Data accessibility*Data are provided with this article*

**Value of the data**•Data show the radioprotective effect of emodin *in vivo*. It is never reported before.•The importance of using morphological features based on symptoms of gastrointestinal acute radiation symptom can serve as a guideline to facilitate recognition and quantification of these radiation-induced gastrointestinal tract injury.•p53 apoptosis signaling pathways are the probable molecular mechanism of emodin radioprotective effect.

1. Data {#s0005}
=======

The data showed associated information on emodin against radiation induced mortality ([Fig. 1](#f0005){ref-type="fig"}), intestinal injury ([Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}), apoptosis ([Fig. 3](#f0015){ref-type="fig"}) and expression of p53 gene ([Fig. 5](#f0025){ref-type="fig"}).

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Experimental design and materials {#s0015}
--------------------------------------

Male C57BL/6 mice were purchased from SIPPR-BK Experiment Animal Co. (Shanghai, China). Human umbilical vein endothelial cells (HUVECs) from ALLCells, LLC (Emeryville, CA, USA). Emodin (purity ≥98%) was purchased from Dalian Meilun Biology Technology CO. (Dalian, China).

2.2. Method {#s0020}
-----------

Mice were randomly divided into different groups, and treated different groups with according to the experiment design. The mice survival rates of mice were calculated using the Kaplan--Meier method, then H&E staining, TUNEL staining and tissue Western blot assay were used to analysis the mice intestinal injury [@bib1], [@bib2]. To assess the effect of emodin on HUVECs *in vitro*, using different concentration emodin to treat HUVECs. Using MTT assay, flow cytometry, Hoechst 33258 staining,real-time PCR and Western blot to detect the changes in cell viability,apoptosis,gene and protein [@bib3].

Transparency document. Supplementary material {#s0030}
=============================================
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![Experimental design schematic picture for animal survival rate (A) and emodin protects mice against radiation-induced death after 9Gy total body irradiation (B). (*n*=10; \**p*\<0.05, emodin treatment group *vs.* radiation group).](gr1){#f0005}

![Data on emodin treatment (30 mg/kg/day) attenuate radiation-induced (7Gy) intestinal injury in mice. (A)(B) Representative micrographs of H&E-stained sections of the proximal jejunum. Significant changes were observed emodin treatment attenuated jejunum injury at 7 days post-irradiation. (C) Emodin pretreatment significant increases the villus length and crypts as well as reduces goblet cells number in the irradiated mice at 7 days after 7Gy TBI. (*n*=5; ^\#^*p*\<0.05, ^\#\#^*p\<*0.01, control group *vs.* radiation group; ^\*^*p*\<0.05, ^\*\*^*p*\<0.01, emodin treatment group *vs.* radiation group.).](gr2){#f0010}

![Apoptotic changes in crypt (A) and villi (B) of jejunum tissue. Original magnification 200x.(C)Quantification of TUNEL-positive cells in crypt and villus per group. Values are presented as mean±SEM (*n*=5;^\#\#^*p*\<0.01, control group *vs.*radiation group;^\*^*p*\<0.05*,*^\*\*^*p*\<0.01,emodin treatment group *vs.* radiation group.).](gr3){#f0015}

![Data on emodin suppresses the radiation-induced expression of p53 for 7 days in the small intestine. Values are presented as the mean±SEM. (*n*=5; ^\#\#^*p*\<0.01*,* control group *vs.*radiation group; \**p*\<0.05*,* emodin treatment group *vs.* radiation group).](gr4){#f0020}

![Data on Emodin increased cell viability and reduced apoptosis of HUVECs after gamma irradiation (24Gy). (A)Improvement in the HUVECs survival rate after irradiation in the emodin-treated group (10, 1, and 0.1 µM). (B)and(D) Annexin V/PI double staining assessed using flow cytometry. (C)and(E)Hoechst 33258 staining was performed to evaluate apoptosis in the HUVECs. Emodin was added at 24 h prior to exposure to radiation, then both cell viability and cell apoptosis were analyzed at 24 h post-irradiation. Values are presented as the mean±SEM (*n*=3;^*\#*^*p*\<0.05,^*\#\#*^*p*\<0.01, ^*\#\#\#*^*p*\<0.001*,*control group *vs.* radiation group; ^*\**^*p*\<0.05,^*\*\**^*p*\<0.01, emodin treatment group *vs .*radiation group).](gr5){#f0025}
